CARECLOUD INC Stock Price, News & Analysis

CareCloud (NASDAQ: CCLD) reported strong financial results for full year 2024, marking a significant turnaround with a GAAP net income of $7.9 million compared to a $48.7 million loss in 2023. The company achieved revenue of $110.8 million and increased Adjusted EBITDA by 56% to $24.1 million.

Key highlights include a 244% increase in free cash flow to $13.2 million and strong Q4 2024 performance with $3.3 million in net income. The company completed strategic financial moves including converting 3.5 million Series A Preferred Stock into 26 million common shares, reducing annual dividend burden by $7.7 million, and fully repaying its Silicon Valley Bank credit line.

Looking ahead to 2025, CareCloud projects revenue of $111-114 million, Adjusted EBITDA of $26-28 million, and EPS of $0.10-0.13. The company attributes its improved performance to AI-driven innovation and operational efficiency.

CareCloud (Nasdaq: CCLD) has announced its intention to voluntarily delist its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (CCLDP) from the Nasdaq Global Market. This decision follows a mandatory conversion of Series A Preferred Stock into common stock, where each share was converted into 7.3358 shares of the company's common stock. The conversion excluded 'material shareholders' who owned at least 100,000 shares of Series A Preferred Stock.

The company plans to file a Form 25 with the SEC around March 21, 2025, with the delisting expected to become effective by March 31, 2025. The delisting is being initiated as the security no longer meets Nasdaq's continued listing requirements following the conversion.

CareCloud (CCLD) has announced the mandatory conversion of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock into Common Stock. The conversion, effective March 6, 2025, at 4:01 p.m. Eastern Time, will convert each preferred share into 7.3358 shares of Common Stock, including all accumulated and unpaid dividends.

This strategic move will eliminate approximately $7 million in annual dividend obligations, allowing the company to reinvest capital in growth initiatives. According to Norman Roth, Interim CFO, the conversion will result in a cleaner capital structure and enhanced flexibility for shareholder value creation.

Shareholders owning at least 100,000 preferred shares as of the Mandatory Exchange Date retain the right to object to the conversion. Fractional shares will be rounded up to the next whole share, and dividends on converted shares will cease to accrue on the conversion date.

CareCloud (CCLD) has announced the acquisition of MesaBilling, marking its first acquisition since Q2 2021 and signaling a renewed focus on strategic growth. The deal, finalized on February 28, 2025, though described as 'very small,' represents the company's return to its aggressive expansion strategy.

Between 2012 and 2022, CareCloud completed over 20 acquisitions, achieving a >30% compound annual growth rate (CAGR). The company plans to leverage its AI-powered revenue cycle management and automation tools to expand its healthcare provider network through this acquisition.

MesaBilling's Managing Member Marc Dobberstein expressed optimism about providing clients access to CareCloud's broader services and AI technology. Co-CEO Stephen Snyder indicated this acquisition marks the beginning of a new wave of strategic acquisitions and partnerships.

CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider for medical practices and health systems, has scheduled its fourth quarter and full year 2024 financial results announcement for March 13, 2025, before market opening. The company will host a conference call for investors at 8:30 a.m. Eastern Time.

Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only by dialing 201-389-0920. A replay will be available approximately three hours after the call's conclusion at the same link, with an audio-only option available at 412-317-6671 (access code: 13751992).

CareCloud (Nasdaq: CCLD) has announced the transfer of funds for January 2025 dividend payments on its Series A and Series B Preferred Stock. Series A stockholders will receive 22.917 cents per share, while Series B stockholders will receive 18.229 cents per share, based on the January 31, 2025 record date.

The payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025. Both Series A and Series B Preferred Stock dividends are cumulative and payable monthly in arrears on the 15th of each month or the next business day. Due to President's Day on February 17th, payments will begin processing on February 18th.

CareCloud (Nasdaq: CCLD) has launched a new advanced referral module for its AI-enabled EHR system, achieving up to 70% time savings in referral management. The module streamlines the referral process through automation and location-based guidance, receiving an exceptional rating from 92% of surveyed users.

Key features include real-time referral completion during patient visits, location-based specialist recommendations, secure patient notifications via text messages, seamless appointment booking, and easy access to referral documentation through Personal Health Record (PHR). The system enables providers to complete referrals during patient visits and allows patients to receive specialist recommendations with integrated maps, book appointments directly, and access their referral forms securely.

CareCloud (Nasdaq: CCLD) has successfully completed its SOC 2 Type 2 examination for the second consecutive year, receiving a clean report with no exceptions. The examination, conducted by an independent CPA firm, covered security, availability, processing integrity, and confidentiality of Healthcare IT systems.

This achievement places CareCloud among an exclusive group representing less than 10% of all EHR vendors with such attestation. The certification validates the company's robust security infrastructure and demonstrates its capability to protect sensitive healthcare data, particularly important for larger enterprises such as health systems and hospital networks.

The attestation positions CareCloud for expanded growth into larger client bases, including health systems, multi-specialty group practices, and enterprise-level healthcare organizations that require stringent security and compliance frameworks for their operations.

CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.

The company's management team will deliver a corporate presentation highlighting recent developments and strategic initiatives. They will also engage in one-on-one meetings with institutional and individual investors. Co-CEO Stephen Snyder emphasized several key milestones, including the planned resumption of Preferred Stock dividends in February 2025, shareholder approval for increasing authorized common shares, and strong profitability growth during 2024.